Female sexuality is drastically affected by emotional state and, of course, depression. Two in every ten women is having hypoactive sexual desire disorder characterizing immensely reduced responses to sexual interaction. While developing an effective antidepressant, the drug under the investigation of Boehringer Ingelheim pharmaceuticals was found to increase sexual responses in females rather than to act simply as an anti-depressant. Clinical trials were performed and the efficacy of the drug in enhancing female sexuality was verified.
Flibanserin is a potential HSDD cure replacing the hormonal treatments for the depressed female sexuality that poses a number of harmful side effects. 100mg tablet to be administered once a day for at least a week elicits pronounced increase in the desire for a female to have sexual activity. Some of the side effects of the drug include dizziness, nausea, urinary infections, headache and fatigue.
Flibanserin does not increase the blood flow to genitals. Instead it controls neuronal excitation of CNS towards sexual responses relieving depression and emotional stress simultaneously. The drug is a serotonin type 1a and dopamine D-4 receptor agonist and 5-HT type 2a receptor antagonist. This way, the drug nourishes the emotional tone of the affected female making her increasingly vulnerable to physical interaction.
Being the future of female sexual enhancers, the recently developed drug flibanserin, the first of its kind, could be ordered affordably from our online pharmacy. Give your sexual desires a new life by flibanserin and experience the desire of physical pleasures like never before.